Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate vs Tranexamic Acid for Heavy Menstrual Bleeding
NCT03027973Phase 1Withdrawn
- Sponsor
- University of Saskatchewan
- Start
- Jan 2020
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ulipristal in Heavy menstrual bleeding, sponsored by University of Saskatchewan. Primary endpoint: Menorrhagia Multi-attribute Scale at 3 months. Planned start Jan 2020; status: withdrawn.
02
Drugs
ulipristal
03
Conditions
Heavy menstrual bleeding
Beyond the preview
Go deeper on NCT03027973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03027973.